Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 11 clinical trials
Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P

An open label, multicentre, international pilot study of paritaprevir/ritonavir, ombitasvir, dasabuvir with or without ribavirin or glecaprevir/pibrentasvir for people with recently acquired

  • 15 views
  • 25 Jan, 2021
  • 11 locations
Development of a Community-based HCV Treatment Completion Intervention Among HCV Positive Homeless Adults

) period. Homeless adults assigned to the CHW/RN HCV treatment group will receive culturally-sensitive education, case management, and daily DOT delivery of Mavyret (pibrentasvir/glecaprevir) by an RN

  • 0 views
  • 26 Jan, 2021
  • 2 locations
Transplantation Using Hepatitis C Positive Donors A Safety Trial

. Prior to transplantation, recipients will receive an initial dose of highly effective antiviral prophylaxis using approved direct-acting antivirals (DAAs) Glecaprevir/Pibrentasvir (G/P) and they will

pibrentasvir
antiviral drugs
glecaprevir
  • 10 views
  • 23 Jan, 2021
  • 1 location
Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients

This study is being conducted to determine safety and effectiveness of transplanting kidneys from Hepatitis C-positive donors into Hepatitis C-negative patients on the kidney transplant waitlist, who will then be treated with the appropriate direct-acting antiviral (DAA) after the single kidney transplantation.

kidney transplant
dialysis
  • 0 views
  • 27 Jan, 2021
  • 1 location
An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs

Post-marketing surveillance study to evaluate the real world safety and effectiveness of Maviret (Glecaprevir/Pibrentasvir) administered under a normal, routine treatment practice by Korean

pibrentasvir
chronic hepatitis
glecaprevir
  • 16 views
  • 24 Jan, 2021
  • 58 locations
Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination

A community-based "test and treat" intervention integrating point-of-care HCV RNA testing, non-invasive liver disease assessment and linkage to care will lead to a reduction in HCV prevalence among people attending Aboriginal health services.

hepatitis
sofosbuvir
glecaprevir/pibrentasvir
glecaprevir
liver disease
  • 60 views
  • 25 Jan, 2021
  • 4 locations
Study of Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12 Years or Older With Chronic Hepatitis C to Assess Sustained Virological Response

to cirrhosis (scarring of the liver), liver cancer or the need for liver transplant. This study will evaluate how effective glecaprevir/pibrentasvir (GLE/PIB) is in participants with chronic HCV

  • 0 views
  • 26 Jan, 2021
  • 1 location
A Study of the Effectiveness and Clinical Practice Use of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Genotypes 1 to 6 in Russian Federation

The objective of this study is to assess the effectiveness of the glecaprevir/pibrentasvir (GLE/PIB) regimen in adolescent participants aged 12 to <18 years of age with chronic hepatitis C

HIV Infection
hcv genotype
ribavirin
cirrhosis
sofosbuvir
  • 2 views
  • 25 Jan, 2021
  • 5 locations
A Study Describing the Care Cascade and Effectiveness and Safety of Glecaprevir/Pibrentasvir in Adult Participants With Hepatitis C Virus in French Addiction Centers

and safety of Glecaprevir/Pibrentasvir among patients treated in addiction centers and evolution of addiction behavior after treatment are of specific interest. Glecaprevir/Pibrentasvir is a

cirrhosis
glecaprevir
liver disease
antiviral drugs
ribonucleic acid
  • 0 views
  • 25 Jan, 2021
  • 45 locations
A Study of the Safety Effectiveness and Clinical Use of Maviret in Adolescent Patients With Chronic Hepatitis C Virus

This study will assess the safety and effectiveness of Maviret (Glecaprevir plus Pibrentasvir (GLE/PIB)) in adolescent participants diagnosed with chronic hepatitis C (CHC) in a real world

pibrentasvir
chronic hepatitis
glecaprevir
  • 1 views
  • 30 Jan, 2021
  • 1 location